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Unnatural amino acids carrying reactive groups that
can be selectively activated under non-invasive biologi-
cally benign conditions are of interest in protein engi-
neering as biological tools for the analysis of protein-
protein and protein-nucleic acids interactions. The
double ring system phenylalanine analogues benzofura-
nylalanine and benzotriazolylalanine were synthesized,
and their photolability was tested by UV irradiation at
254, 320, and 365 nm. Although both showed photo reac-
tivity, benzofuranylalanine appeared as the most prom-
ising compound because this amino acid was activated
by UVA (long wavelength) irradiation. These amino ac-
ids were also tested for in vitro charging of tRNAPhe and
for protein mutagenesis via the phenylalanyl-tRNA syn-
thetase variant A294G that is able to facilitate in vivo
protein synthesis using a range of para-substituted phe-
nylalanine analogues. The results demonstrate that ben-
zofuranylalanine, but not benzotriazolylalanine, is a
substrate for phenylalanine tRNA synthetase A294G,
and matrix-assisted laser desorption ionization time-of-
flight analysis showed it to be incorporated into a model
protein with high efficiency. The in vivo incorporation
into a target protein of a bicyclic phenylalanine ana-
logue, as described here, demonstrates the applicability
of phenylalanine tRNA synthetase variants in expand-
ing the scope of protein engineering.
The use of unnatural amino acids for protein engineering is
a rapidly developing technology that adds new dimensions to
conventional mutagenesis by allowing introduction of novel
chemical and biological functionality into proteins (1). Esche-
richia coli has been the organism most widely used for in vivo
unnatural amino acid incorporation (e.g. 2–5), but eukaryotic
host systems (6–8) have also recently been described. The
development of all such systems is dependent on engineering
the substrate specificity of the aminoacyl tRNA synthetases or
of the tRNA-aminoacyl tRNA synthetase pair. The aminoacyl
tRNA synthetases charge tRNA with cognate amino acid before
delivery of the aminoacyl-tRNA by elongation factor Tu to the
ribosome for incorporation into nascent polypeptide (9). One
approach to the development of unnatural amino acid recogni-
tion involves selective mutagenesis of the relevant aminoacyl
tRNA synthetase to recognize amino acid analogues that are
close structural mimics of the cognate amino acid (2, 3). For
instance, an E. coli phenylalanine tRNA synthetase (PheRS)1
variant carrying a single Ala3 Gly amino acid substitution at
-subunit residue 294 (PheRS-A294G) (10) displays relaxed
substrate specificity in vivo toward a number of para-substi-
tuted phenylalanine mimics. Examples include several haloge-
nated phenylalanines including p-chlorophenylalanine (2), p-
bromophenylalanine (11) and p-iodophenylalanine as well as
p-cyanophenylalanine, p-ethynylphenylalanine, p-azidopheny-
lalanine, and 2-,3-, and 4-pyridylalanine (12). Introducing the
additional mutation Thr 3 Gly in position 251 (PheRS-
T251G/A294G) further enlarges the amino acid binding
pocket, which provides space for phenylalanine analogues car-
rying modifications on the benzene ring and allows activation
of still larger unnatural amino acids such as p-acetylphenylala-
nine (3).
Based upon previous studies of proteinogenic photoreactive
amino acid analogues with bicyclic structures containing a
benzene ring “scaffold” (13), we set out to test such compounds
as substrates for incorporation into a protein via PheRS-
A294G. Other unnatural amino acids shown to be substrates
for this aminoacyl tRNA synthetase variant display distinct yet
limited structural divergence from phenylalanine. In contrast,
the presently tested analogues, benzofuranylalanine and ben-
zotriazolylalanine (Fig. 1), contain an additional five-mem-
bered ring system fused to the benzene ring of phenylalanine.
Although PheRS-A294G (and PheRS-T251G/A294G) appear
rather flexible with respect to modifications at the para posi-
tion of the benzene side chain, it is far from obvious that this
mutant would accommodate amino acids carrying double ring
systems involving joint substitutions at the meta and para
position of the phenylalanine benzene side chain. Nevertheless,
based on growth inhibition, we have previously proposed that
benzofuranylalanine is indeed a substrate for PheRS-A294G,
opening up the possibility that such bicyclic amino acid analogs
could be developed as substrates for protein synthesis (13).
We now present in vitro results showing that benzofurany-
lalanine is a substrate for aminoacylation of tRNAPhe by
PheRS-A294G and directly demonstrate the in vivo incorpo-
ration of this amino acid analogue into a model protein using E.
coli strains expressing mutant PheRS -subunits and wild type
tRNAPhe. In addition, another photoreactive and structurally
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related amino acid, benzotriazolylalanine, was synthesized and
tested as a substrate for activation and aminoacylation.
EXPERIMENTAL PROCEDURES
Synthesis—All intermediate products have been obtained as mix-
tures of isomers (named as XZ) in a ratio of 1:1, as determined by high
performance liquid chromatography. NMR data for XZ derivatives are
given for two isomer products.
5-Hydroxymethyl-N-benzyl-benzotriazole (1XZ)—5-Hydroxymethyl-
benzotriazole (14) (7.5 g, 50 mmol) and K2CO3 (4.0 g, 29 mmol) were
suspended in acetonitrile (50 ml). Benzylbromide (10.2 g, 60 mmol) was
added, and the mixture was stirred overnight at room temperature. The
reaction mixture was evaporated to dryness in vacuo. The residue was
dissolved in ethyl acetate and extracted with NaHCO3 (saturated aque-
ous solution). The organic phase was dried over MgSO4 and reduced in
an oil. This oil was a mixture of three benzylation products at positions
N1, N2, and N3 (Scheme 1). The isomers N1 and N3 were isolated as an
unseparable mixture (5.5 g, 46%) by silica gel column chromatography
eluting with ethyl acetate/n-hexane (2:1 v/v). FAB-MS m/z 240 (MH)
data: 1H NMR (Me2SO-d6):  8.0–7.2 (m, 16H), 5.97 (s, 4H), 5.47 (t, 2H,
J  5.5 Hz), 4.67 (d, 4H, J  5.5 Hz); 13C NMR (Me2SO-d6):  145.55,
138.93, 135.88, 131.90, 128.72, 127.98, 127.60, 127.48, 126.90, 118.71,
115.89, 110.26, 107.11, 62.65, 50.95, 50.73.
2-Acetamino-2-carbethoxy-3-(N-benzyl-benzotriazole-5-yl)propanoic
acid ethyl ester (3XZ)—Compound 1XZ (4.6 g, 19 mmol) was suspended
in dichloromethane (100 ml). Phosphorous tribromide (5.5 g, 20 mmol)
was added dropwise. After 4 h of stirring the reaction mixture was
extracted with ice-cold water (2  100 ml) and subsequently with
saturated aqueous NaHCO3 (2  50 ml). The organic phase was dried
over MgSO4 and evaporated to dryness in vacuo. The remaining oil
(5-bromomethyl-N-benzyl-benzotriazole, 2XZ) was added to a freshly
made solution of sodium diethyl acetamidomalonate (prepared by treat-
ment of diethyl acetamidomalonate (4.3 g, 20 mmol) with sodium hy-
dride (60% dispersion in oil, 800 mg, 20 mmol) in dry tetrahydrofuran
(100 ml) for 30 min and subsequent filtration of the salt and drying in
vacuo for 30 min) in dry Me2SO (10 ml) and stirred for 15 min at room
temperature under nitrogen. The reaction mixture was taken into wa-
ter (200 ml) and extracted with ethyl acetate (2  100 ml). The organic
phase was dried over Na2SO4 and evaporated to dryness in vacuo. The
residue was purified by silica gel column chromatography eluting with
ethyl acetate/n-hexane (1:1 v/v), and 3XZ was obtained as colorless
crystals (7.8 g, 89%). FAB-MS m/z 439 (MH) data: 1H NMR (CDCl3):
 7.9–6.9 (m, 16H), 6.48 and 6.38 (2s, 2H), 5.71 (s, 4H), 4.2-4.0 (m, 8H),
SCHEME 1. Steps during synthesis of benzotriazolylalanine.
FIG. 1. Chemical structure of the photoreactive amino acid
analogues used in this study. 1, benzofuranylalanine; 2,
benzotriazolylalanine.
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3.70 and 3.67 (2s, 4H), 1.93 and 1.75 (2s, 6H), 1.2 (m, 12H); 13C NMR
(CDCl3):  169.11, 169.06, 167.05, 166.91, 145.60, 144.82, 135.35,
134.33, 134.10, 132.70, 131.89, 131.66, 129.79, 129.28, 128.83, 128.80,
128.36, 128.25, 127.44, 126.92, 126.117, 120.06, 119.25, 110.49, 109.40,
67.05, 66.85, 62.63, 62.55, 62.35, 52.27, 51.94, 37.77, 37.35, 22.82, 22.60,
13.80, 13.72.
N-Acetyl-3-(N-benzyl-benzotriazole-5-yl)-DL-alanine Ethyl Ester
(4XZ)—Compound 3XZ (3.0 g, 6.8 mmol) and lithium chloride (2 g) were
dissolved in a mixture of water (2 ml) and N,N-dimethylformamide (80
ml) and heated to 140 °C for 18 h. The solvent was then removed in
vacuo, and the residue was taken up in water (50 ml). The aqueous
phase was extracted with ethyl acetate (3  100 ml), and the combined
organic phases were dried over Na2SO4 and evaporated to dryness in
vacuo. The solid residue was purified by silica gel column chromatog-
raphy, eluting with ethyl acetate. 4XZ was obtained as colorless crys-
tals (2.3 g, 92%). FAB-MS m/z 367 (MH) data: 1H NMR (CDCl3): 
7.9–7.0 (m, 16H), 6.3 and 6.2 (2d, 2H, J  7.0 Hz), 5.81 (s, 4H), 4.95 (m,
2H), 4.2-4.0 (m, 4H), 3.2 (m, 4H), 2.0 and 1.9 (2s, 6H), 1.2–1.0 (m, 6H);
13C NMR (CDCl3):  171.40, 171.30, 169.96, 169.89, 145.83, 144.96,
136.52, 134.61, 134.37, 133.10, 132.98, 132.13, 129.54, 129.12, 128.69,
128.59, 127.72, 127.48, 126.29, 119.85, 110.05, 110.00, 61.79, 61.71,
61.59, 53.40, 53.24, 52.64, 52.30, 41.53, 38.15, 37.88, 23.15, 23.07, 14.19.
LN-Acetyl-3-(N-benzyl-benzotriazole-5-yl)-L-alanine (5XZ)—Com-
pound 4XZ (2.2 g, 6 mmol) was dissolved in a mixture of Me2SO (30 ml)
and phosphate buffer (pH 7.5, 0.1 M, 50 ml). Carlsberg subtilisin (20 mg
dry weight) was added, and the mixture was stirred overnight at room
temperature. Water (50 ml) was added, and non-reacted ethyl ester
(D-form) was removed by extraction with ethyl acetate (3  100 ml). The
pH of the aqueous phase was adjusted to 2.5 by the addition of diluted
HCl and extracted with ethyl acetate (4  100 ml). The organic phase
was evaporated in vacuo to an oil, which was dissolved in water (100 ml)
and freeze-dried.5XZ was obtained as a white powder (840 mg, 40%).
FAB-MS m/z 339 (MH) data: 1H NMR (CD3OD):  7.9–7.2 (m, 16H),
5.9 (s, 4H), 4.7 (m, 2H), 3.4-3.0 (m, 4H), 1.9 and 1.7 (m, 6H); 13C NMR
(CD3OD):  171.40, 171.10, 169.89, 145.83, 144.96, 136.70, 136.26,
134.77, 133.95, 132.60, 130.47, 130.10, 129.57, 128.98, 127.38, 120.91,
112.51, 52.17, 53.19, 52.98, 41.54, 37.50, 37.20, 23.16, 23.07.
L-3-(N-Benzyl-benzotriazole-5-yl)-L-alanine Hydrochloride (6XZ)—
Compound 5XZ (700 mg, 2 mmol) was dissolved in 5 N HCl (50 ml) and
heated under reflux for 4 h. After cooling, the solvent was removed in
vacuo, and the solid residue was dissolved in tetrahydrofuran (5 ml).
This solution was drained into diethyl ether (50 ml), and 6XZ was
collected as a white powder by filtration (650 mg, 93%). FAB-MS m/z
297 (MH) data: 1H NMR (CD3OD): 7.9–7.2 (m, 16H), 5.9 (s, 4H), 4.7
(m, 2H), 3.5–3.2 (m, 4H); 13C NMR (Me2SO-d6):  171.10, 145.85,
144.95, 136.70, 136.26, 134.77, 133.95, 132.60, 130.46, 130.10, 129.57,
128.98, 127.38, 120.91, 120.77, 112.51, 55.16, 55.18, 52.98, 50.42,
37.49, 37.20.
FIG. 2. UV spectra and photolability of benzofuranylalanine. A–C, irradiation at increasing wavelengths as indicated. Left panel, selected
spectra from the irradiation time course. Right panel, UV absorbance at the indicated wavelength as a function of irradiation time. The
benzofuranylalanine concentrations used were 0.2 mM (A) and 5 mM (B and C).
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6XZ (600 mg, 2 mmol) was dissolved in glacial acetic acid (5 ml) and
hydrogenated at 5.5 atm in the presence of catalytic amounts of Pd on
charcoal for 48 h. The catalyst was removed by filtration, and the
filtrate evaporated to dryness in vacuo. The residue was triturated with
diethyl ether, and the product was obtained as a white powder (400 mg,
96%). FAB-MS m/z 207 (MH) data: 1H NMR (CD3OD):  8.05 (m, 2H),
7.74 (d, 1H, J  9.1 Hz), 4.47 (t, 1H, J  6.5 Hz), 3.7-3.4 (ABX-system,
JAB  17.5 Hz, JAX  6.0 Hz, JBX  7.2 Hz);
13C NMR (CD3OD): 
161.20, 128.26, 127.84, 127.26, 122.36, 122.15, 121.39, 106.40, 45.35.
High resolution mass spectrometry results for C9H11N4O2 were
207.0882 (calculated) and 207.0881 (experimental).
UV Irradiation—Aqueous solutions of benzofuranylalanine and ben-
zotriazolylalanine at the indicated concentrations in a quartz cuvette
sealed with Parafilm were placed immediately adjacent to the desired
UV light source with the following characteristics: Struers UVG-11, 254
nm; Philips TL20W/12RS, 320 nm; Phillips 20 W/09N, 365 nm. Samples
were irradiated at room temperature for the desired length of time. At
the desired time intervals the cuvette was removed, and the UV ab-
sorption spectrum was recorded using a Cary 300 Bio UV-visible spec-
trophotometer (Varian).
Charging and Competition Analyses—Wild type and A294G E. coli
PheRS were purified as previously described (10). E. coli tRNAPhe was
from Sigma. Pyrophosphate (PPi) exchange and aminoacylation reac-
tions were performed as described (10), with unlabeled benzofurany-
lalanine included at 2 and 4 mM for the determination of inhibition
constants during aminoacylation. The direct attachment of benzofura-
nylalanine and benzotriazolylalanine to in vitro transcribed tRNA was
monitored by direct 32P labeling of tRNAPhe using E. coli tRNA-terminal
nucleotidyltransferase (15) followed by aminoacylation and product
visualization as previously described (16).
Expression Analyses—In vivo incorporation of benzofuranylalanine
into recombinant murine dihydrofolate reductase (DHFR) was per-
formed as previously described using the phenylalanine auxotrophic
FIG. 3. UV spectra and photosensitivity of the benzotriazolylalanine. A–C, irradiation at different wavelengths as indicated. Left panel,
selected spectra from the irradiation time course. Right panel, UV absorbance at the indicated wavelength as a function of irradiation time. A
benzotriazolylalanine concentration of 0.4 mM was used throughout.
TABLE I
Steady-state kinetic parameters for aminoacylation by
A294G PheRS with [14C]-phenylalanine in the presence
of [12C]-benzofuranylalanine (Bzf)
Bzf Km kcat Ki
a
mM M Phe min1 M Bzf
0 20.2  6 211  27 NA
2 159  39 179  24 291  110
4 333  100 163  26 258  110
a Ki was determined from the following formula KMapp  KMreal (1 
Bzf/Ki). Phe, phenylalanine; NA, not applicable.
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strains AF-1Q/pQE-15 (PheRS  wild type) and AF-1Q/pQE-FS
(PheRS-A294G mutant) (11). An overnight culture was diluted into
fresh M9 minimal media supplemented with the 20 amino acids at 20
g/ml and the antibiotics ampicillin (100 g/ml) and chloramphenicol
(40 g/ml) and grown to an A600 of 0.6–1.0. The cells were harvested by
centrifugation, washed twice in 20 ml of ice-cold 0.9% NaCl, and resus-
pended in fresh M9 media containing antibiotics and all natural amino
acids except phenylalanine. The cells were separated into aliquots of
1–2-ml fractions and supplemented with benzofuranylalanine (2 mM)
and phenylalanine (0.1 mM) as indicated, grown for 10 min at 37 °C,
induced with 1 mM isopropyl-1-thio--D-galactopyranoside, and then
grown for 4–5 h at 30 °C. 100 l of cells grown in the presence of
phenylalanine (and the A600/ml normalized amount of cells grown with
unnatural amino acid) were harvested by centrifugation. The pellet was
resuspended in 20 l of B-PER (Pierce) and 20 l of 2x SDS loading
buffer and heated to 90 °C for 5–10 min, and 10 l was analyzed using
12% acrylamide-SDS page minigels followed by Coomassie Brilliant
Blue staining.
Protein Purification—Protein purification was done using strain AF-
1Q/pQE-FS (PheRS-A294G mutant) from 10 ml of M9 minimal media
cultures supplemented with 19 amino acids (20 g/ml) and benzofura-
nylalanine (2 mM) or phenylalanine (0.1 mM) as described (3) and using
nickel nitrilotriacetic acid chromatography spin columns under dena-
turing conditions as recommended (Qiagen). Buffer exchange from 8 M
urea, 100 mM sodium phosphate, pH 4.5, into water was done using 2 ml
Amicon 10-kDa cutoff ultrafiltration spin filters.
Mass Spectrometry—Mass spectrometry analyses were performed
using a SpectraChrom Kompact MALDI II instrument from Kratos.
MALDI-TOF samples were prepared by mixing 1 l of protein sample
(0.2–0.25 g) per 4 l of matrix (-cyano-4 hydroxycinnamic acid at 10
mg/ml in 50% acetonitrile 50% H2O). The samples were spotted onto
MALDI-TOF slides using 4.5 l per application. Chymotrypsinogen A
(25,657 Da) and -lactoglobulin A (18,364 Da) were used as calibration
standards. The slide was examined for “sweet spots” before running the
experiment. 250 profiles were accumulated per sample.
RESULTS AND DISCUSSION
Synthesis of Bicyclic Amino Acids—Benzofuranylalanine
was synthesized as previously reported (13), and the novel
benzotriazolylalanine was prepared as shown in Scheme 1
starting from commercially available 5-(hydroxymethyl)tria-
zole using standard chemistry. Enantiomeric resolution was
achieved using Carlsberg subtilisin (13) for specific hydrolysis
of the L-form of an ester intermediate.
Photochemistry of the Unnatural Amino Acids—The [22]
photocycloadditions of alkenes are extremely specific and often
of high (quantum) yields. These could therefore be very useful
for sequence-specific post-modification of proteins, provided an
activated alkene with appropriate absorbance characteristics
can be site specifically incorporated into a protein, since no
other functionality of similar reactivity is naturally present in
proteins.
Benzofurans undergo [22] photocycloaddition with a vari-
ety of alkenes (e.g. Ref. 17), although the furan double bond is
only weakly activated by the adjacent oxygen. However, ben-
zofurans also undergo other photochemical reactions. To study
the photosensitivity of benzofuranylalanine, the compound was
irradiated at different wavelengths, and the corresponding UV
absorption spectra were recorded over time (Fig. 2). Upon ir-
radiation at 254 nm the absorption peak at 245 nm declined,
and a “shoulder” peak with a maximum of 342 nm appeared
with similar kinetics (estimated t1⁄2, 50 min) compatible with
a photochemical reaction (Fig. 2A). However, because most
proteins (due to the presence of aromatic amino acids) and all
nucleic acids as well as other cell components have strong
absorption at 254 nm, many unwanted side reactions are bound
to occur both in vitro and especially in vivo upon such irradia-
tion. Conversely, considerably fewer photoreactions take place
in biological systems upon irradiation at longer wavelengths.
Consequently, we also irradiated the amino acids at 320 and
365 nm, where the benzofuran chromophore exhibits a weak
absorption (max  342 nm), now focusing on the UV spectra in
the range 300–400 nm (Fig. 2, B and C). At 320 nm of irradi-
ation, both the spectral changes as well as the time course of
the change in absorbance at the initial absorbance maximum of
342 nm (Fig. 2B) clearly show that at least two photochemical
transformations take place, a fast reaction with an estimated
t1⁄2 of  6 min and a subsequent slow reaction over many hours.
Strikingly, at 365 nm of UVA irradiation only the fast compo-
nent was observed. We have not attempted to analyze the
actual products at this stage, but these results clearly demon-
strate the photosensitivity of the benzofuran ligand, and thus,
its potential utility as a photochemical handle upon incorpora-
tion into proteins. A potential caveat of using UVA irradiation
(, 335 nm) involves the formation of photo adducts between
thiouridine and cytidine at positions 8 and 13 in some tRNAs of
E. coli (18), causing an amino acid starvation response. Once
the cells are removed from UV exposure, however, the effects
are reversed, and they recover by synthesis of new functional
tRNAs (19).
Benzotriazoles undergo photochemical reactions reminiscent
of the highly photosensitive azides. The predominant photore-
action involves release of molecular nitrogen (N2) and forma-
tion of a radical species that may either undergo radical inser-
tion reactions or nucleophilic addition reactions (e.g. Ref. 20),
both giving rise to chemical cross-linking. Upon incorporation
FIG. 4. PheRS-A294G aminoacylates tRNAPhe with benzofura-
nylalanine. tRNAPhe was labeled as previously described (16). The
reaction contained 100 mM Hepes, pH 7.2, 10 mM MgCl2, 30 mM KCl, 2
mM ATP, 1 M E. coli tRNAPhe (Roche Applied Science), and a trace (3.5
nCi) of 3	 32P-labeled tRNAPhe, and aminoacylation was performed at 1
M tRNA and 1 nM wild type PheRS (diamonds and squares) or A294G
mutant (triangles and circles) with 2 mM Phe (diamonds and triangles)
or 0.2 mM benzofuranylalanine (squares and circles).
FIG. 5. Expression analysis of benzofuranylalanine incorpora-
tion by PheRS-A294G. Analysis of total protein content from AF-
1Q/pQE-FS (lanes 1–4) or AF-1Q/pQE-15 (lanes 5–8). The cells were
incubated as described under “Experimental Procedures” with the in-
dicated amino acids. Positions for a protein molecular weight marker
are indicated on the left side of the gel. Bzf, benzofuranylalanine; wt,
wild type.
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into a protein, the benzotriazole ligand would constitute a site
for specific photochemical cross-linking to an interacting bio-
logical ligand, e.g. another protein or a nucleic acid.
Irradiation at 254 and 320 nm of the benzotriazolylalanine
resulted in pronounced spectral changes, fully compatible with a
single photochemical conversion taking place (isosbestic points
are observed at least at shorter irradiation times), with an esti-
mated t1⁄2 of 60 min (Fig. 3, A and B). These results support the
potential use of this amino acid for site-specific photosensitiza-
tion of proteins if incorporated. However, at 365 nm of irradiation
(at which wavelength the benzotriazole does not show any sig-
nificant absorption) no spectral changes were observed, indicat-
ing that this wavelength cannot be utilized for induction of pho-
tochemical reactions using the benzotriazolylalanine.
Steady-state Kinetics for Bicyclic Amino Acids—To investi-
gate charging with unnatural amino acids, we first tested the
ability of benzofuranylalanine and benzotriazolylalanine to in-
hibit aminoacylation of tRNAPhe. Benzofuranylalanine did not
show any inhibition of the wild type enzyme (data not shown)
but acted as a competitive inhibitor for PheRS-A294G (Table
I). In contrast, the addition of benzotriazolylalanine had no
effect on aminoacylation by either form of PheRS. To further
investigate whether benzofuranylalanine might be a substrate
for activation by the mutant form of the enzyme, PPi exchange
analysis was performed. The PPi exchange reaction showed
that benzofuranylalanine is a substrate for PheRS-A294G,
with a Km of 2.3  0.4 mM and a kcat of 923  65 min
1. PPi
exchange with the wild type enzyme showed some low but
inconsistent activity, suggesting that benzofuranylalanine
might be poorly activated. As expected, phenylalanine showed
a higher reaction rate, and no activity at all was seen when the
reaction was performed without substrate.
We also tested benzofuranylalanine and benzotriazolylala-
nine directly as substrates for the aminoacylation of 3	-[32P]-
tRNAPhe (Fig. 4). Benzofuranylalanine was found to be a sub-
strate for aminoacylation by A294G but not wild type PheRS,
and benzotriazolylalanine was a substrate for neither enzyme.
These results are consistent with the kinetic analyses and
confirm that benzofuranylalanine, but not benzotriazolylala-
nine, can be attached to tRNAPhe by PheRS-A294G. In addi-
tion they indicate that benzofuranylalanine, in contrast to nat-
ural non-cognate amino acids, is not a substrate for the
hydrolytic proofreading activity of PheRS (10).
In Vivo Incorporation of Bicyclic Amino Acids—To test
whether benzofuranylalanine and/or benzotriazolylalanine are
in vivo protein synthesis substrates, we used a phenylalanine
auxotrophic E. coli strain encoding PheRS-A294G on an epi-
some (strain AF-1Q/pQE-FS) and the isogenic strain lacking
the mutant tRNA synthetase-encoding gene (strain AF-1Q/
pQE-15) as a control. Both strains harbor an isopropyl-1-thio-
-D-galactopyranoside-inducible expression cassette encoding
murine DHFR carrying a short histidine tag (shtDHFR). As
previously reported (11), both strains show abundant overpro-
duction of shtDHFR upon the addition of isopropyl-1-thio--D-
galactopyranoside in the presence of phenylalanine (Fig. 5,
compare lanes 1 with 2 and lane 5 with 6). However, only strain
AF-1Q/pQE-FS produced large amounts of shtDHFR when sub-
stituting benzofuranylalanine for phenylalanine (compare
lanes 3 and 7). In fact, in the presence of wild type PheRS alone
shtDHFR production did not increase beyond background
when conducting the experiment with benzofuranylalanine.
These results indicate that benzofuranylalanine is indeed an in
vivo substrate for PheRS-A294G and, consistent with the in
vitro data, is not utilized by wild type PheRS. A slight but
notable expression of shtDHFR was observed even in the ab-
sence of added phenylalanine or benzofuranylalanine (lanes 4
and 8). This was previously ascribed to residual cellular pools
of phenylalanine remaining even after extensive washing of the
cells (3, 11). Similar analyses were conducted using the benzo-
triazolylalanine. Consistent with the in vitro data, no shtDHFR
production above background was observed upon the addition
of benzotriazolylalanine (data not shown). We also tested the
strain AF-1Q/pQE-T251G/A294G carrying a double mutant
PheRS -subunit (3) for incorporation of unnatural amino acids
FIG. 6. Mass spectrometry analysis
of benzofuranylalanine incorpora-
tion into shtDHFR. Shown are exam-
ples of mass spectra showing shtDHFR
expressed in the presence of benzofuranyl-
alanine (A) and phenylalanine (B). The
molecular masses obtained for this partic-
ular experiment are indicated. Protein
mass determination was calculated as the
mean of 4–5 experiment repetitions. The
molecular weights obtained  S.D. is
24,284  119 (shtDHFR containing ben-
zofuran) and 23,957  76 (shtDHFR-
Phe), and these masses are statistically
significantly different (double-sided Stu-
dent’s t test for data with equal variance,
p 
 0.005; n  9). The calculated mass of
shtDHFR-Phe is 24040. Sequencing of the
shtDHFR-coding region revealed no
amino acid alterations as compared with
the published sequence (Qiagen, plasmid
pQE15). The discrepancy of the found and
calculated masses of shtDHFR-Phe are
therefore ascribed to experimental
inaccuracy.
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into shtDHFR. In accordance with the data obtained using
strain AF-1Q/pQE-FS, the double mutant utilized benzofura-
nylalanine but showed no shtDHFR expression above back-
ground in the presence of benzotriazolylalanine (data now
shown). Thus, benzofuranylalanine, but not benzotriazolylala-
nine, is a substrate for PheRS T251/A294G.
Analysis of Benzofuran-containing shtDHFR—Because ben-
zofuranylalanine (Mr 205) has a larger mass as compared with
phenylalanine (Mr 165), incorporation of benzofuran into the
reporter protein should be readily detectable as a significant
mass increase of shtDHFR containing benzofuran. Mass spec-
trometry analysis of purified protein revealed molecular
masses of 24,284 and 23,957 Da for shtDHFR expressed in the
presence of benzofuranylalanine and phenylalanine, respec-
tively (Fig. 6). This clearly demonstrates the incorporation of
unnatural amino acid and corresponds to an average of 8
benzofuranylalanine replacements in nine possible positions.
Conclusions—The data presented show that benzofurany-
lalanine, but not benzotriazolylalanine, is an efficient substrate
for cellular protein synthesis as a result of its ability to be
attached to tRNAPhe by PheRS-A294G. These findings are of
potential interest in the development of novel protein cross-
linking methodologies given that benzofuranylalanine was
found to be photoreactive at UVA wavelengths. The effective
application of such methodologies is dependent on site-specific
replacement of particular residues with benzofuranylalanine
rather than global insertion in response to all phenylalanine
codons as described here. Although a completely site-specific
system may require extensive mutagenesis of both PheRS and
a tRNAPhe-derived suppressor species or perhaps another pair
(4), existing heterologous codon-biased systems offer the poten-
tial to replace designated Phe residues with benzofuranylala-
nine in certain targets (21, 22).
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